Empowered Funds LLC Purchases Shares of 329,042 Concentrix Corporation $CNXC

Empowered Funds LLC purchased a new position in Concentrix Corporation (NASDAQ:CNXC) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 329,042 shares of the company’s stock, valued at approximately $7,372,000.

A number of other large investors have also modified their holdings of CNXC. Royal Bank of Canada raised its stake in shares of Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after acquiring an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Concentrix by 75.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after purchasing an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Concentrix by 17.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock worth $8,152,000 after purchasing an additional 21,746 shares in the last quarter. Focus Partners Wealth purchased a new stake in Concentrix during the 1st quarter worth about $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the period. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Price Performance

Concentrix stock opened at $29.38 on Monday. The stock has a market cap of $1.79 billion, a PE ratio of -1.38, a P/E/G ratio of 0.54 and a beta of 0.45. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18. The stock’s fifty day moving average is $24.62 and its two-hundred day moving average is $27.07. Concentrix Corporation has a 1-year low of $19.12 and a 1-year high of $57.88.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings data on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same period in the prior year, the company posted $2.70 earnings per share. The company’s revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, sell-side analysts expect that Concentrix Corporation will post 9.67 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 4th. Investors of record on Friday, July 24th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Friday, July 24th. Concentrix’s dividend payout ratio is -6.75%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research note on Friday, July 24th. Barrington Research cut their target price on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Robert W. Baird reduced their target price on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Zacks Research downgraded shares of Concentrix from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 2nd. Finally, Bank of America decreased their price target on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research note on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $32.75.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.